In addition, the present results suggest a strategy for the development of a method to prevent and treat the cognitive impairment associated with delayed CO encephalopathy; antidepressants such as TCAs, SSRIs, and SNRIs may be useful by increasing FGF2 expression in astrocytes. The gene discussed is FGF2; the disease is Cognitive impairment.